This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. (September 2023) |
The topic of this article may not meet Wikipedia's general notability guideline. (December 2024) |
EuropaBio ("The European Association for Bioindustries") is Europe's largest and most influential biotech industry group, whose members include leading large-size healthcare and industrial biotechnology companies.[1] EuropaBio is located in Brussels, Belgium. The organisation was initiated in 1996 to represent the interests of the biotechnology industry at the European level, and therefore influence legislation that serves the interests of biotechnology companies in Europe.[2]
| Company type | Advocacy group |
|---|---|
| Industry | Biotechnology |
| Founded | 1996 |
| Headquarters | Brussels, Belgium |
Key people |
|
| Website | www |
Activity and goals
editEuropaBio is engaged in dialogue with the European Parliament, the European Commission, and the Council of Ministers to influence legislation on biotechnology.
EuropaBio represents two sectors of the biotech industry.
- White or industrial biotechnology is the application of biotechnology for industrial purposes, including manufacturing, alternative energy (or "bioenergy") biofuels, and biomaterials.
- Red or healthcare biotechnology is the application of biotechnology for the production of medicines and therapies.
EuropaBio's stated goals are:
- promoting an innovative, coherent, and dynamic biotechnology-based industry in Europe;
- advocating free and open markets and the removal of barriers to competitiveness with other areas of the world;
- committing to an open, transparent, and informed dialogue with all stakeholders about the ethical, social, and economic aspects of biotechnology and its benefits;
- championing the socially responsible use of biotechnology to ensure that its potential is fully used to the benefit of humans and their environment.[3]
EuropaBio's primary focus is the European Union but because of the global character of the biotech business, it also represents its members in transatlantic and worldwide forums.
Organisation
editEuropaBio has a board of management made up of representatives from among its industry members. Since 2023, Dr. Sarah Reisinger representing dsm-firmenich is chair of the board.
The board is assisted by sectoral councils representing the main segments of EuropaBio – healthcare (red biotech), and industrial (white biotech).
Additionally, National Associations are represented through the National Associations Council.
Experts from member companies and national associations participate in EuropaBio's working groups which cover a very wide range of issues and areas of concern of biotech enterprises.
Since November 2020 EuropaBio Director General is Dr. Claire Skentelbery.[4]
Members
editIn 2021, the association represents 79 corporate and associate members and BioRegions, and 17 national biotechnology associations in turn representing over 1800 biotech SMEs.[5]
See also
editCitations
edit- ^ "Members – Europabio".
- ^ "About us – Europabio". Retrieved 2022-11-23.
- ^ "About us – Europabio". Retrieved 2021-08-18.
- ^ "EuropaBio announces Dr. Claire Skentelbery as new Director General of the Association". Retrieved 2021-08-18.
- ^ "Members – Europabio". Retrieved 2021-08-18.
References
edit- Transforming Europe’s position on GM food - ambassadors programme executive summary The Guardian, Thursday 20 October 2011, Guardian News and Media Limited.
- Biotech group bids to recruit high-profile GM 'ambassadors' John Vidal and Hanna Gersmann, The Guardian, Thursday 20 October 2011, Guardian News and Media Limited.
- Draft letter from EuropaBio to potential GM ambassadors The Guardian, Thursday 20 October 2011, Guardian News and Media Limited.